Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The protein encoded by ST14 is an epithelial-derived, integral membrane serine protease. Zusätzlich bieten wir Ihnen Suppression of Tumorigenicity 14 (Colon Carcinoma) Antikörper (104) und Suppression of Tumorigenicity 14 (Colon Carcinoma) Proteine (7) und viele weitere Produktgruppen zu diesem Protein an.
Showing 1 out of 8 products:
Activation of proHGF by St14 induces mouse embryonic stem cell differentiation.
The authors report that ST14/Prss14 is an emerging therapeutic target for breast cancer where HER2 (zeige ERBB2 ELISA Kits) is not applicable.
These results identify EpCAM (zeige EPCAM ELISA Kits) as a substrate of matriptase and link HAI-2 (zeige SPINT2 ELISA Kits), matriptase, EpCAM (zeige EPCAM ELISA Kits), and claudin-7 (zeige CLDN7 ELISA Kits) in a functionally important pathway that causes disease when it is dysregulated.
Matriptase is present in macrophages from patients with mutated alpha-1 antitrypsin (zeige SERPINA1 ELISA Kits) at high levels and contributes to their proteolytic activity on extracellular matrix. MMP-14 (zeige MMP14 ELISA Kits) is a novel substrate for matriptase, which regulates the levels of MMP-14 (zeige MMP14 ELISA Kits) on the cell surface. High levels of matriptase may contribute to increased ECM (zeige MMRN1 ELISA Kits) degradation by Z-M, both directly and through MMP-14 (zeige MMP14 ELISA Kits) activation.
Ultraviolet irradiation/reactive oxygen species induced matriptase proteolysis may have short term protective effects and contribute to the recovery from acute epidermal damage and/or pathology of skin with chronic sun damage.
The present study demonstrated that ovarian cancer cell metastasis and invasion were more dependent on upregulation of matriptase levels than downregulation of HAI1 (zeige SPINT1 ELISA Kits). Matriptase may be a potential adjuvant therapeutic target for inhibiting ovarian cancer invasion and metastasis.
Given that matriptase-1 participates in terminal KC differentiation, its absence in psoriatic skin lesions indicates that this contributes to the barrier disturbances in this disease.
Novel findings reveal a new paradigm in matriptase activation involving PDGF-D (zeige PDGFD ELISA Kits)-specific signal transduction leading to extracellular acidosis.
Maritriptase is required for pro-HGF/c-Met signaling and cell proliferation in breast cancer cells.
Matriptase inhibition by HAI-2 (zeige SPINT2 ELISA Kits) requires the translocation of HAI-2 (zeige SPINT2 ELISA Kits) to the cell surface, a process which is observed in some breast cancer cells but not in mammary epithelial cells.
The proliferation impairment in matriptase-deficient breast cancer cells is caused by their inability to initiate activation of the c-Met signalling pathway in response to fibroblast-secreted pro-HGF (zeige HGF ELISA Kits).
Matriptase is a critical promoter of late stages of squamous cell carcinoma progression and induces pro-tumorigenic chemokine (zeige CCL1 ELISA Kits) and cytokine release, and inflammatory cell accumulation in established tumors.
Data show that proteinase-activated receptor (PAR)-2-dependent inflammatory signaling as an essential component of matriptase-mediated and potentiation of ras-mediated oncogenesis.
HAI-1 (zeige SPINT1 ELISA Kits) regulates the activity of activated matriptase, whereas HAI-2 (zeige SPINT2 ELISA Kits) has an essential role in regulating prostasin (zeige PRSS8 ELISA Kits)-dependent matriptase zymogen activation.
Our results reveal unexpected complementary roles of matriptase-prostasin (zeige PRSS8 ELISA Kits)- and PAR-2 (zeige F2RL1 ELISA Kits)-dependent proteolytic signaling in the establishment of placental epithelial barrier function and overall embryonic survival.
These findings suggest that TGF-beta (zeige TGFB1 ELISA Kits) induces epithin/PRSS14 shedding by mediating translocation of epithin/PRSS14 sheddase, TACE (zeige ADAM17 ELISA Kits), to the membrane.
Matriptase deletion initiates a Sjogren's syndrome-like disease in mice.
Matriptase is required for the active form of hepatocyte growth factor (zeige HGF ELISA Kits) induced Met, focal adhesion kinase and protein kinase B (zeige AKT1 ELISA Kits) activation on neural stem/progenitor cell motility.
ST14 expression is downregulated in colitis.
The protein encoded by this gene is an epithelial-derived, integral membrane serine protease. This protease forms a complex with the Kunitz-type serine protease inhibitor, HAI-1, and is found to be activated by sphingosine 1-phosphate. This protease has been shown to cleave and activate hepatocyte growth factor/scattering factor, and urokinase plasminogen activator, which suggest the function of this protease as an epithelial membrane activator for other proteases and latent growth factors. The expression of this protease has been associated with breast, colon, prostate, and ovarian tumors, which implicates its role in cancer invasion, and metastasis.
membrane-type serine protease 1
, serine protease 14
, serine protease TADG-15
, suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin)
, suppressor of tumorigenicity 14 protein
, tumor associated differentially expressed gene 15 protein
, tumor-associated differentially-expressed gene 15 protein
, matriptase a
, suppression of tumorigenicity 14 (colon carcinoma) a
, suppressor of tumorigenicity 14 protein homolog
, suppressor of tumorigenicity protein 14
, protease, serine, 14 (epithin)
, membrane-type serine protease